Clinical Decision Support Systems (CDSS) Market Size & Forecast Report, 2013 - 2024

Global Clinical Decision Support Systems Market is expected to reach USD 791.25 million by 2024. Clinical Decision Support System is also termed, as CDSS is an application that recognizes data to support healthcare providers make clinical decisions. It is a version of the decision support system exclusively used to support business management. To prepare a diagnosis and evaluation of the diagnosis as a means of refining the concluding result. The Clinical Decision Support System (CDSS) Market is estimated to grow at a significant CAGR of 6.7% over the future period as the scope and its applications are rising enormously across the globe.

The increasing government initiatives, growing aging population, acceptance of HCIT solutions in healthcare, and a growing number of people suffering from chronic diseases are documented as major factors of the clinical decision support systems industry that are estimated to enhance the growth in the years to come. However, the saturated end-user market and lack of skilled personnel are the factors that may restrain overall market growth in the forecast period. The clinical Decision Support System industry is segmented based on types, product types, delivery mode, components, user inactivity, application, and region.

Diagnostics CDSS and Standalone CDSS are the types that could be explored in Clinical Decision Support Systems in the years to come. Various product types of Clinical Decision Support System could be explored in the forecast period are Integrated CDSS with CPOE & E.H.R., Standalone CDSS, Integrated E.H.R. with CDSS, Integrated CPOE with CDSS, and others. Clinical Decision Support System integrated with CPOE segment accounts for the largest market share of the overall market and is estimated to lead the market in the coming years. Moreover, it is estimated to grow at the highest CAGR in the upcoming years. This may be because of, acceptance of computerized prescription patterns in developed regions.

The market is categorized based on a delivery mode like On-Premises Delivery, Web Delivery, Cloud Delivery, and others. The On-premises model is exclusively preferred due to information safety and privacy issues. It is estimated to lead the overall market in the years to come. Also, the cloud-based delivery segment is estimated to grow at the highest CAGR in the upcoming years.

The software sector is at the topmost position due to the need for intervallic software upgradation. However, Services and Hardware are other components that could be explored in Clinical Decision Support System in the future period. The services may include Post-sale and Maintenance Services, Consulting Services, Training and Education Services, and Ongoing IT support and Implementation Services.

Passive CDSS and Active CDSS are the user interactivity that could be explored in Clinical Decision Support System in the upcoming years. Also, the market is categorized based on applications like Drug Dosing Support, Drug-Drug Interactions, Clinical Guidelines, Drug Allergy Alerts, Clinical Reminders, and others. The drug allergy alerts sector is estimated to lead the overall market in the foremost period. However, drug dosing support and drug-drug interactions follow suit.

Globally, North America accounts for the largest market share of the Clinical Decision Support System and is estimated to remain dominant in the years to come. The reason behind the growth of the market in this region could be, the rising importance of the quality of healthcare services, technological enhancement, and presence of reimbursement policies. The United States may be a major consumer of Clinical Decision Support System in this region in the forecast period. Instead, Europe and the Asia Pacific are also estimated to have a positive influence on future growth.

However, Asia Pacific is estimated to grow at the fastest pace with the highest CAGR of 7.8% in the years to come. The aspects that may be ascribed to the growth comprise, increasing investments in the healthcare sector in countries like Singapore, Australia, India, and China. In addition, developing countries like India and China are the major consumers of Clinical Decision Support systems in this region.

The key players of the Clinical Decision Support System Market are Siemens Healthcare, EPIC Systems Corporation Inc., Phillips Healthcare, International Business Machines (IBM), Cerner Corporation, Elsevier B.V., McKesson Corporation, Zynx Health, Medical Information Technology, Inc., Wolters Kluwer Health, and Allscripts Healthcare Solutions. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.

Market Segment:

Clinical Decision Support Systems Product Outlook (Revenue, USD Million, 2013 - 2024)
    • Standalone CDSS
    • Integrated CPOE with CDSS
    • Integrated E.H.R. with CDSS
    • Integrated CDSS with CPOE & E.H.R.

Clinical Decision Support Systems Application Outlook (Revenue, USD Million, 2013 - 2024)
    • Drug-drug interactions
    • Drug allergy alerts
    • Clinical reminders
    • Clinical guidelines
    • Drug dosing support
    • Others

Clinical Decision Support Systems Delivery Mode Outlook (Revenue, USD Million, 2013 - 2024)
    • Web Delivery
    • Cloud Delivery
    • On-Premises Delivery

Clinical Decision Support Systems Component Outlook (Revenue, USD Million, 2013 - 2024)
    • Hardware
    • Software
    • Services

Clinical Decision Support Systems Regional Outlook (Revenue, USD Million, 2013 - 2024)
    • North America
        • the U.S.
        • Canada
    • Europe
        • Germany
        • the U.K.
    • the Asia Pacific
        • Japan
        • China
    • Latin America
        • Brazil
    • the Middle East and Africa (MEA)
        • South Africa